Pathology and Microbiology-II (MBG-201): Online resources

Publisher of more than 160 peer-reviewed focus on medical related subjects, open access journals, The research articles in all journals published by BioMed Central are ‘Open Access’. They are immediately and permanently available online.

DOAB is a community-driven discovery service that indexes and provides access to scholarly, peer-reviewed open access books and helps users to find trusted open access book publishers. All DOAB services are free of charge and all data is freely available.

PubMed® comprises more than 36 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full text content from PubMed Central and publisher web sites.

Access to 3405 full text journals from computer science, mathematics, engineering, geosciences.

Taylor & Francis have been publishing academic research since 1798 and on an open access basis since 2006.

Wiley-Inter science is an STM (Science, technology, and Medicine) and SSH (Social Sciences and Humanities) publisher. Introduced in 1997, Wiley Inter Science is a leading international resource for scientific, technical, medical and scholarly content. In June 2008.

Clinical Pharmacology: Advances and Applications is an international, peer-reviewed, open access, online journal, that focuses on the publication of Clinical Trials with a special interest in Early Clinical Trials and the pharmacologic behavior of drugs and agents.

The journal aims to serve both the academic and industrial communities and it is dedicated to publishing rapidly all scientifically sound Clinical Trials. Clinical Trials submitted to the journal should report detailed pharmacologic information/data. The journal aims at publishing articles that will allow predictions to be made from drug chemistry and pharmacology for eventual benefits and side effects.

Expert Review of Clinical Pharmacology [ISSN 1751-2433]; [e-ISSN 1751-2441] is a MEDLINE-indexed, international subscription-based journal publishing rigorously peer-reviewed review articles and original papers on all aspects of clinical safety, tolerability, efficacy and therapeutic applications.

The journal also covers toxicity issues, adverse reactions, pharmacoeconomics, and societal issues. Adverse reactions experienced at the clinical trial level serve as a constant reminder of the importance of rigorous safety and toxicity testing. Furthermore, the advent of pharmacogenomics and ‘individualized’ approaches to therapy will demand a fresh approach to drug evaluation and healthcare delivery.

Expert Review of Pharmacoeconomics & Outcomes Research [ISSN 1473-7167]; [e-ISSN 1744-8379] is a MEDLINE-indexed, international subscription-based journal publishing rigorously peer-reviewed review articles and original research papers on health economics, pharmacoeconomics and outcomes, relating to all health technologies including; drugs, therapeutic approaches, medical devices, and prevention.

Articles focus on the following key areas:

Health technology assessment and health economics
Health economic evaluation (cost-effectiveness), pharmacoeconomics and budget impact analyses
Outcomes research including therapeutic outcomes and health preference research
Quality of life, economic burden and cost of illness.

Geriatric Pharmacology is an Open Access peer-reviewed journal publishing research contributions that improve our understanding of how current pharmaceuticals behave in older adults and how newly developed pharmaceuticals will affect this patient group. The journal welcomes robust basic, translational, and clinical research on the development of treatments for conditions that typically affect older adults and covers topics such as omics applied to drug discovery and development, cellular and animal studies, dosage and adherence, clinical safety, deprescribing, polypharmacy, drug delivery, precision medicine, pharmacoepidemiology, and pharmacovigilance. We also welcome contributions on the use of artificial intelligence and machine learning techniques for precision medicine, clinical studies in younger participant cohorts that have direct relevance for preventing and managing disease states in the older patient population, and qualitative studies on the use of medicine in older patients.

The Journal of Experimental Pharmacology (JEP) is an esteemed international, peer-reviewed, open-access online journal covering various aspects of laboratory and experimental pharmacology. JEP serves as a platform for disseminating cutting-edge discoveries in the field, facilitating advancements and discussions in experimental pharmacology and related disciplines.